Partnering for Increased Biosimilar Market Share: Alvotech Partners with Cipla Gulf


Alvotech, a privately-owned biopharmaceutical company out of Reykjavik, Iceland, announced a partnership with Cipla Gulf FZ LLC for the commercialization of a biosimilar (AVT02 – an adalimumab biosimilar) in emerging markets. AVT02 is a biosimilar to AbbVie’s Humira with indications for several autoimmune diseases, such as Rheumatoid Arthritis. In...

Emerson Collective Invests in an Icelandic Medical Fish Skin Company


Kerecis, an Icelandic medical device company and pioneer in using fish skin in tissue regeneration, recently announced a $16m series C financing round. The funds will be used to increase sales and marketing in the United States and Switzerland. According to media coverage in Iceland, Emerson Collective, which was founded by Laurene Powel Jobs, is o...

Icelandic MedTech Company Engages with Women’s College Hospital in Toronto


Medilync, a medical technology company from Iceland, has announced their work with the Women’s College Hospital Institute for Health Systems and Solutions and Virtual Care (WIHV) in Toronto, Ontario. Medilync was selected among a delegation of 15-Nordic companies to visit the hospital and care centers in Toronto. WIHV completed a comprehensive eval...

Combating Prediabetes and Type-2 Diabetes with a Mobile Health Engagement App


Behavioral engagement is viewed as a core mitigator in the fight against lifestyle disease, such as prediabetes and type-2 diabetes. Driven by research presented at the American Diabetes Association Scientific Sessions, an Icelandic mobile health-engagement platform in the form of an app can help promote weight loss and adherence to in-person lifes...

Medilync partners with National Hospital and Receives Horizon 20/20 grant


Medilync, a medical device company from Iceland, is focusing on improving the lives of patients with diabetes by improving the ease of disease self-management. Cloudlync, their flagship software, contains computer vision that facilitates the accurate logging of insulin doses administered via analogue insulin pens. Diabetes care management is comple...

Icelandic research receives 2.5m USD in international funding for unique biobank


The Landspítali University Hospital in Iceland has received a grant of 2.5m USD (ISK 300 million) to build a biobank in connection with one of the most comprehensive scientific studies ever conducted in the world. A total of 80,000 people in Iceland participate in the study titled iStopMM (Iceland Screens Treats or Prevents Multiple Myeloma). The g...

The Icelandic Centre for Research funds 61 research projects for 2019


The Icelandic Centre for Research (Rannis) has funded 61 new research projects for grant year 2019 from a total pool of 359 applications. Funded projects include those from industry, as well as the University of Iceland, Reykjavik University and the National University Hospital. In addition, postdoctoral and doctoral grants were awarded to 27 stude...

Icelandic Biotech Companies to Toronto Health Innovation Week


The 6th Annual Health Innovation Week in Toronto will take place from April 1-5, 2019. During this week a group of Nordic companies will be visiting Toronto under the auspice of the Nordic-Canada Health Solutions Initiative. This is a collaboration project to assist Nordic healthcare companies with accelerated entry to the Canadian market. Among th...

Kerecis Acquires Swiss Life-Science Company and Gains Reimbursement Approval


Kerecis, an Icelandic medical device company, announced two big milestones recently pertaining to the Swiss market: first, the acquisition of a Swiss life-science company, Phytoceuticals; second, the approval from Swiss healthcare authorities that the company’s lead product (Kerecis Omega3 Wound) will be reimbursed in Switzerland. As of March 1, 20...

Page 1 of 3 | Next

Get in touch

For further information on the benefits of establishing a business in Iceland please feel free to contact us.